20% of randomly chosen chromatograms - In any Guideline? [Bioanalytics]

posted by Obinoscopy  – USA, 2018-06-04 00:50 (2942 d 01:36 ago) – Posting: # 18850
Views: 11,369

Hi ElMaestro,

Thanks for your response.

❝ It is in the guidelines to the same extent as the requirement for cherry-picking the 20%.


Lol @ cherry-picking. But yeah, that should be a concern for the Sponsor or even the Regulator as the CRO site could cherry-pick runs of samples with wonderfully looking Chromatogram. However I noticed the FDA Guideline did state that chromatogram for NDAs and BLAs be randomly selected while chromatogram for ANDAs be serially selected. Which is great. I hope EMA considers this in subsequent reviews.

❝ Make sure to have an SOP which gives an objective way to select them.


Yea, the draft FDA Guideline did state that. But it was not stated in the final FDA guideline.....strange.

Regards,

Scopy

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
121 visitors (0 registered, 121 guests [including 22 identified bots]).
Forum time: 02:26 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5